**ÀϽÃ: 2015.5.16(Åä)
**Àå¼Ò: ÆĶó´ÙÀ̽ºÈ£ÅÚ ºÎ»ê

 

5/16(Åä) Grand Ballroom 1 Grand Ballroom 2 Grand Ballroom 3 Capri Room Sydney
06:50~07:20 Registration   Poster
Exhibition
07:20~07:30 Opening  
07:30~08:30 ¿¬±¸ºñ ¹× ÀåÇÐ±Ý º¸°í  
08:30~10:00 Á¤Ã¥°úÁ¦ ¹ßÇ¥  
10:00~10:30 Coffee Break  
10:30~12:00 Plenary Session  
12:00~12:20 ÀÓ½ÃÃÑȸ  
12:20~12:50 Coffee Break  
12:50~13:50 Luncheon Symposium  
13:50~14:00 Coffee break  
14:00~15:30 Concurrent Symposium 2
(Liver)
Concurrent Symposium 1
(Basic)
Concurrent Symposium 3
(Thoracic)
Concurrent Symposium 4
(Kidney)
15:30~16:00 Coffee break  
16:00~17:30 Concurrent Symposium 6
(Liver)
Concurrent Symposium 5
(Organ Donation)
Concurrent Symposium 7
(Coordinator)
Concurrent Symposium 8
(Kidney)
17:30 Closing

  ³»¿ë ÁÂÀå/¿¬ÀÚ
06:50~07:20 Registration
07:20~07:30 Opening ±èµ¿±¸(°¡Å縯ÀÇ´ë,
´ëÇÑÀ̽ÄÇÐȸ ȸÀå)
07:30~08:30 ¿¬±¸ºñ ¹× ÀåÇÐ±Ý º¸°í ÁÂÀå: Á¤ÁØÇå(ÇѼ­º´¿ø)
À¯Èñö(ÀüºÏÀÇ´ë)
07:30~07:50 Outcomes After steatotic Liver Transplantation Á¶À翵(¼­¿ïÀÇ´ë)
07:50~08:10 Transplantation for hilar cholangiocarcinoma ±è¹ü¼ö(°æÈñÀÇ´ë)
08:10~08:30 Primate Allo-islet Transplantation Modeling ¹ÚÀç¹ü(¼º±Õ°üÀÇ´ë)
08:30~10:00 Á¤Ã¥°úÁ¦ º¸°í ÁÂÀå: ±èµ¿±¸(°¡Å縯ÀÇ´ë)
ÇÑ´öÁ¾(¿ï»êÀÇ´ë)
08:30~08:50 ½ÅÀå ¹× °£À̽Ŀ¡¼­ Ç×ü¸Å°³ °ÅºÎ¹ÝÀÀÀÇ ÀÓ»ó-º´¸®ÇÐÀû Ư¡ Á¤ÇöÁÖ(¿¬¼¼ÀÇ´ë)
08:50~09:10 KOTRY °æ°ú º¸°í ±è¸í¼ö(¿¬¼¼ÀÇ´ë)
09:10~09:30 KONOS 2014³âµµ º¸°í ±èÅÃ(KONOS)
09:30~09:45 Çѱ¹Àå±â±âÁõ¿ø ¼º°úº¸°í ÇÏÁ¾¿ø(KODA)
09:45~10:00 2014 »ý¸íÀձ⠻ç¾÷ º¸°í Á¶¿øÇö(»ý¸íÀÕ±â)
10:00~10:30 Coffee Break
10:30~12:00 Plenary Session ÁÂÀå: À̼®±¸(¼º±Õ°üÀÇ´ë)
±èÀ¯¼±(¿¬¼¼ÀÇ´ë)
10:30~11:30 Ethical considerations and outcomes for live kidney donors. Peter Reese(University of Pennsylvania)
11:30~12:00 3D printing : '3rd Industrial Revolution' and Translational Research" ÀÌÁø¿ì(°¡Ãµ´ë)
12:00~12:20 ÀÓ½ÃÃÑȸ
12:20~12:50 Coffee Break
12:50~13:50 Luncheon Symposium 1(¾Æ½ºÅÚ¶ó½º) ÁÂÀå: ¹Ú¼ö±æ(¿ï»êÀÇ´ë)
±è¸í¼ö(¿¬¼¼ÀÇ´ë)
  ADV in De-novo Jeff Zaltzman(Nephrologist, Canada)
12:50~13:50 Luncheon Symposium 2(Á¾±Ù´ç) ÁÂÀå: ±èÀ¯¼±(¿¬¼¼ÀÇ´ë)
¹®Àμº(°¡Å縯ÀÇ´ë)
  Generic formulation of Tacrolimus, TacroBell®, in de novo kidney transplant recipients: six-year experience. Çã¿ì¼º(¼º±Õ°üÀÇ´ë)
  Experiences of Mizoribine (Bredinin®) as Antimetabolite for Kidney Transplantation (Single center experience) ¿ÀÁؼ®(ºÀ»ýº´¿ø)
12:50~13:50 Luncheon Symposium 3(³ì½ÊÀÚ) ÁÂÀå: ¼­°æ¼®(¼­¿ïÀÇ´ë)
Á¶Àç¿ø(¼º±Õ°üÀÇ´ë)
  The development of HBIG Gene might open new era for prophylaxis in HBV-infected liver transplant patioents Á¤µ¿È¯(¿ï»êÀÇ´ë)
13:50~14:00 Coffee Break
14:00~15:30 Concurrent Symposium 1(Basic): New technology for transplantation ÁÂÀå: Á¶È«·¡(¿ï»ê´ëº´¿ø)
¾çö¿ì(°¡Å縯ÀÇ´ë)
14:00~14:30 Blastocyst complementation: Towards compensation of organogenesis using pluripotent stem cells ½ÉÈ£¼·(´Ü±¹ÀÇ´ë)
14:30~15:00 Xenotransplantation ¾È±Ô¸®(¼­¿ïÀÇ´ë)
15:00~15:30 Antibody drug conjugate (ADC) for transplantation Á¤ÁØÈ£(¼­¿ïÀÇ´ë)
14:00~15:30 Concurrent Symposium 2(Liver): How to make safe living donation ÁÂÀå: Á¶Àç¿ø(¼º±Õ°üÀÇ´ë)
¼­°æ¼®(¼­¿ïÀÇ´ë)
14:00~14:30 Donor evlaluation and graft type selesction to minimize the risk ÁÖÁ¾¿ì(ºÎ»êÀÇ´ë)
14:30~15:00 Donor morbidity is real: How to prevent or manage to avoid long-lasting sequelae Á¤µ¿È¯(¿ï»êÀÇ´ë)
15:00~15:30 Long-term follow-up protocols and outcomes in living liver donor À̳²ÁØ(¼­¿ïÀÇ´ë)
14:00~15:30 Concurrent Symposium 3(Thoracic): Primary graft failure after thoracic transplantation ÁÂÀå: ¹éȿä(¿¬¼¼ÀÇ´ë)
±èÀçÁß(¿ï»êÀÇ´ë)
14:00~14:22 Organ preservation in heart transplantation Á¤¼ºÈ£(¿ï»êÀÇ´ë)
14:22~14:44 Primary graft failure after heart transplantation À±Á¾Âù(¿¬¼¼ÀÇ´ë)
14:44~15:06 Pathophysiology and risk factors of PGD in lung transplantation ±è¼ÛÀÌ(¿¬¼¼ÀÇ´ë)
15:06~15:28 Management of PGD following lung transplantation ±èµµÇü(ºÎ»êÀÇ´ë)
14:00~15:30 Concurrent Symposium 4(Kidney): Safety issues in living kidney donor ÁÂÀå: ±èÁß°æ(ºÀ»ýº´¿ø)
±è¼ºÁÖ(¼º±Õ°üÀÇ´ë)
14:00~14:22 Donor selection ÀÌÁ¾¼ö(¿ï»êÀÇ´ë)
14:22~14:44 Surgical issues in live donor nephrectomy À±¿µÀº(¿¬¼¼ÀÇ´ë)
14:44~15:06 Characteristics and Outcomes of Living Kidney Donors ¾çÀç¼®(¼­¿ï´ëº´¿ø)
15:06~15:28 Panel discussion ÀÌÁ¾¼ö, À±¿µÀº, ¾çÀç¼®
15:30~16:00 Coffee Break
16:00~17:30 Concurrent Symposium 5(Organ Donation): Issues in organ donation ÁÂÀå: Á¤»ó¿µ(Àü³²ÀÇ´ë)
±Ç¿ÀÁ¤(ÇѾçÀÇ´ë)
16:00~16:22 Donation improvement program ÇÏÁ¾¿ø(¼­¿ïÀÇ´ë)
16:22~16:44 School education program ¿ÀÁöÀº(ÇѸ²ÀÇ´ë)
16:44~17:06 Kidney allocation rule ±è¿µÈÆ(ÀÎÁ¦ÀÇ´ë)
17:06~17:28 Liver allocation rule ±è¸í¼ö(¿¬¼¼ÀÇ´ë)
16:00~17:30 Concurrent Symposium 6(Liver): Is the long-term use of immunosuppresion an old friend or
old foe?
ÁÂÀå:Ȳ  ½Å(¿ï»êÀÇ´ë)
À̱¤¿õ(¼­¿ïÀÇ´ë)
16:00~16:30 The metabolic complication related with the long-term use of immunosuppression À̽ÃÈÆ(°¡ÃµÀÇ´ë)
16:30~17:00 CNI-related renal dysfunction in long-term survivors after LT: How to expect and manage ÁÖµ¿Áø(¿¬¼¼ÀÇ´ë)
17:00~17:30 Withdrawl or minimization of the immunosuppresion: Where are we? ¼Û±â¿ø(¿ï»êÀÇ´ë)
16:00~17:30 Concurrent Symposium 7(Coordinator) ÁÂÀå: Àü°æ¿Á(¼¼ºê¶õ½ºº´¿ø)
°­ÇöÁø(KODA)
16:00~17:00 ³ª´Â Àü¹®°¡Àΰ¡? ¼Õ¼±¿µ(¼¼ºê¶õ½ºº´¿ø)
17:00~17:30 Àå±âÀ̽ļ¾ÅÍ ÄÚµð³×ÀÌÅÍÀÇ Àü¹®¼º ±èÇü¼÷(¼­¿ï¼º¸ðº´¿ø)
16:00~17:30 Concurrent Symposium 8(Kidney): Hot issues in post-transplant management ÁÂÀå: ¹®Àμº(°¡Å縯ÀÇ´ë)
¹Ú¼º±¤(ÀüºÏÀÇ´ë)
16:00~16:30 How to manage multidrug-resistant bacterial organisms ±è»óÀÏ(°¡Å縯ÀÇ´ë)
16:30~17:00 How to manage HCV - recipient preparatin and post-transplant management ÀÓ¿µ¼®(¿ï»êÀÇ´ë)
17:00~17:30 How to treat recurrent focal segmental glomerulosclerosis(FSGS) and primary hyperoxaluria ³ë  ÇÑ(°¡ÃµÀÇ´ë)
17:30~ Closing